| Author | Berney, SC. |
|---|---|
| Type | Journal Article (Original Research) |
| Journal | Journal of Physiotherapy |
| PubMed ID | 26947004 |
| Year of Publication | 2016 |
| URL | http://www.sciencedirect.com/science/article/pii/S1836955316000138 |
| DOI | http://dx.doi.org/10.1186/s12890-015-0082-310.1016/j.jphys.2016.02.004 |
| Download |  2016_July_Berney.pdf (80.9 KB) |
| Abstract | Commentary Survivors of acute respiratory failure requiring intensive care unit (ICU) admission and mechanical ventilation frequently suffer enduring impairments of physical function.1 To date, no trial, including that of Moss and colleagues, which commenced an intervention during hospitalisation, has impacted performance-based measures of physical function after hospital discharge. The authors are to be applauded for conducting a trial with high treatment fidelity, and that achieved separation and sample size, as these elements have not always been achieved in rehabilitation trials.2 and 3 However, the results must be viewed with caution. Firstly, the primary outcome (Physical Functional Performance Test score) is not validated in critical illness survivors. The test exhibited a substantial floor effect at the primary time point, with a completion rate of 33% of participants. This increased to 48% at 3 months and 43% at 6 months. Furthermore, as measured by the short form of the Continuous Scale Physical Functional Performance Test score, two participants achieved functional independence on completion of physiotherapy treatment (both in the control group), despite 50% of participants being discharged home. Secondly, a significant between-group difference in age was observed and, although not significant, the intervention group were weaker, had lower bed mobility scores and completed less available rehabilitation days in ICU than the standard care arm, suggesting important differences may have been present at randomisation. Thirdly, although described as an early intervention, intensive treatment was not initiated until a median of 8 days (IQR 6 to 11). Despite the results of this and other rehabilitation trials for critical illness survivors, these studies consistently report a perilous state of physical function beyond hospital discharge.1 and 2 It is important that we continue to seek interventions to improve these outcomes. However, the results of the AVERT trial3 are a salient reminder that we don't yet understand the who, when and how of rehabilitation for survivors of critical illness. |
http://www.ibas.org.au/what-we-do/publications/3872847
Interstitial lung disease (ILD) is a chronic lung condition that causes stiff lungs and restricts sufferers from taking a deep breath. Exercise in a gym, or swimming, walking or riding a bike, can help...
SHIFT WORK AND BREASTFEEDING PROJECT
Researchers at Austin Health are looking for volunteers to participate in a study exploring the impact shift work has on breast milk composition. Participants will be compensated with a $100 gift voucher.
Sleep apnea is a condition where breathing is abnormal during sleep. There are two main forms of sleep apnea: obstructive and central. For obstructive sleep apnea, breathing is reduced because the airway...
A/PROF MARK HOWARD AWARDED MAJOR COMPETITIVE MRFF GRANT
IBAS leads project to revolutionize Home Ventilation with $1.2 million grant for Assoc. Prof Mark Howard's research titled "Synchronise non-invasive ventilation at home".
PROF ANNE HOLLAND RECEIVES PRESTIGIOUS RESEARCH AWARD
Prof Anne Holland receives prestigious award for Excellent in Research Engagement and Impact from Monash University.
WORLD SLEEP DAY ON 17TH MARCH 2023
The benefits of quality sleep and to acknowledge the issue of sleep problems and their medical, educational, and social aspects as well as the prevention and management of sleep disorders, is promoted on World Sleep Day on the 17th March 2023.
A/PROF MARK HOWARD IS LISTED IN 'THE AUSTRALIAN'
The Australian's Research magazine names the top researcher and top research institution in each field of research, based on the number of citations for papers published in the top 20 journals in each field over the past five years.
© 2024 Institute for Breathing and Sleep. All Rights Reserved. ABN 39 093 685 879
Powered by Helmut Design | Manage
